NAV as on 31-01-2023
AUM as on 31-12-2022
Rtn ( Since Inception )
19.44%
Inception Date
Jun 01, 2004
Expense Ratio
2.06%
Fund Status
Open Ended Scheme
Min. Investment
5,000
Min. Topup
1,000
Min. SIP Amount
100
Risk Status
very high
Investment Objective : The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.